All Categories
Refine Search
Solcitinib (GSK2586184A)
Novel signal transduction pathway inhibitor and Janus kinase 1 (JAK1) inhibitor
SOMG-833 Hydrochloride
Novel, selective c-MET inhibitor, blocking c-MET dependent neoplastic effects and exerting antitumor activity
Sonidegib (LDE-225)
An orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity.